A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder.

This study is currently recruiting participants.

Verified by Norwegian University of Science and Technology, July 2006

Sponsors and Collaborators:	Norwegian University of Science and Technology St. Olavs Hospital Norwegian Foundation for Health and Rehabilitation
Information provided by:	Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:	NCT00184301

Purpose

The purpose for this study is to determine whether inpatient treatment is better then intensive outpatient group treatment for patients with concurrent eating disorder and personality disorder.

Condition	Intervention	Phase
Eating Disorder Anorexia Nervosa Bulimia Nervosa, Personality Disorder	Behavioral: Treatment programs	Phase I

MedlinePlus related topics: Eating Disorders Personality Disorders

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Treatment of Patients With Concurrent Eatingdisorder and Personality Disorder: A Controlled Randomized Comparison Study, of Treatments Given to Inpatients and Outpatients.

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:

Score on personality,interpersonal, eatingdisorder and symptom scales

Estimated Enrollment:	40
Study Start Date:	September 2005
Estimated Study Completion Date:	December 2012

Detailed Description:

The main aim of the study is to compare the effects of inpatient treatment with a group based intensive outpatient treatment. It is a randomized controlled comparison study including patients with concurrent eating disorder and personality disorder. 18 patients will receive a inpatient treatment lasting one year. 18 patients will receive intensive outpatient treatment consisting of to weekly grouptratment sessions, lasting one year. Personalitydisorder, eatingbehavior, symptoms, and function will be followed for two years.

Eligibility

Ages Eligible for Study:	18 Years to 45 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Anorexia nervosa, bulimia nervosa, personalitydisorder.

Exclusion Criteria:

male, schizophrenia.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00184301

Contacts

Contact: Are Holen, PhD MD

+4773551500

Are.holen@ntnu.no

Locations

Norway
Østmarka Psychiatric Department, St Olavs Hospital, University Hospital of Trhodheim.	Recruiting
Trondheim, Norway
Contact: Are Holen, PhD MD +4773551500 are.holen@ntnu.no
Contact: Jens Dahl +4773864500 jens.dahl@ntnu.no
Principal Investigator: Are Holen, PhD MD

Sponsors and Collaborators

Norwegian University of Science and Technology

St. Olavs Hospital

Norwegian Foundation for Health and Rehabilitation

Investigators

Principal Investigator:

Are Holen, PhD MD

Norwegian University of Science and Technology

More Information

Study ID Numbers:	064.03
Study First Received:	September 13, 2005
Last Updated:	July 24, 2006
ClinicalTrials.gov Identifier:	NCT00184301
Health Authority:	Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:

Eatingdisorders,
Anorexia nervosa,
Bulimia nervosa,

Personality disorders,
Inpatient treatment,
outpatient treatmet,

Study placed in the following topic categories:

Signs and Symptoms
Bulimia Nervosa
Signs and Symptoms, Digestive
Mental Disorders
Bulimia

Anorexia
Anorexia Nervosa
Eating Disorders
Hyperphagia
Personality Disorders

Additional relevant MeSH terms:

Pathologic Processes
Disease

ClinicalTrials.gov processed this record on January 14, 2009